Table 5.
Matrix | Factor Name | Sequence | Sites Tat−/Meth vs. Tat−/Sal (MSS) | Sites/Sequences Tat−/Meth vs. Tat−/Sal (CSS) | Sites Tat+/Meth vs. Tat−/Meth (MSS) | Sites/Sequences Tat+/Meth vs. Tat−/Meth (CSS) |
---|---|---|---|---|---|---|
V$CPBP_Q6 | KLF6 | 117 | 5.57 | 1627 | 3.86 | |
V$TATA_01 | TBP-related factors | NS | NS | 156 | 2.82 | |
V$BCL6_Q3_01 | BCL-6 factors | 3 | 3.00 | NS | NS | |
V$ZNF333_01 | ZNF333 | 25 | 2.50 | 369 | 1.84 | |
V$MAZ_Q6_01 | MAZ | 10 | 2.50 | NS | NS | |
V$SRY_Q6 | Sox-related factors | NS | NS | 330 | 1.95 | |
V$AP1_03 | AP-1 (JUN/FOS) | 24 | 2.40 | 198 | 2.28 | |
V$ZFP161_04 | ZFP161 | 21 | 2.33 | NS | NS | |
V$SP1_Q6_01 | Sp1 group | 16 | 2.29 | NS | NS | |
V$BEN_01 | BEN | 29 | 2.23 | NS | NS | |
V$NR3C1_03 | GR-like receptors | 8 | 2.00 | NS | NS | |
V$CREBP1_01 | ATF-2 group | 2 | 2.00 | 145 | 2.07 | |
V$P53_04 | TP53 | 4 | 2.00 | 128 | 1.97 | |
V$MYOGENIN_Q6_01 | MYOD1 | 14 | 2.00 | 398 | 2.57 | |
V$BBX_03 | Bbx | NS | NS | 11 | 1.83 |